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The gut microbiota has recently emerged
as an important, and previously unappre-
ciated, player in host physiology (1). In
particular, the gut microbiota contributes
to a variety of physiological and patho-
physiological processes in the host includ-
ing immune disorders (2–4), atheroscle-
rosis (5), irritable bowel syndrome (6, 7),
blood pressure regulation (8), and chronic
kidney disease (9, 10). Bacteria residing in
the human gut are an important compo-
nent of human physiology: the total wet
weight of gut microbes in the human has
been estimated to be 175 g–1.5 kg (11, 12),
and the cells of the microbiota outnum-
ber human cells by 10:1 (1). These bacteria
interact with the immune system of the
host (13), and secrete a variety of metabo-
lites, which enter host circulation and can
affect a variety of physiological parame-
ters (8, 14), reviewed in Ref. (15). In fact,
metabolites produced by the gut micro-
biota have been found to play key roles
in renal disease (16), blood pressure reg-
ulation (8), and immune disorders (2–4).
Therefore, just as we consider the genetic
background of an animal or an individual
to be an important contributing factor to
their physiology, so too must we consider
the genetic background of the microbiota
associated with that animal.
Gut microbiota vary greatly amongst
laboratory animals, and these differences
result in notable differences in experimen-
tal results. Mice of the same strain from
different vendors have different microbiota
profiles (17), and similarly, the same mice
housed at different institutions have dif-
ferent microbiota profiles (18, 19). Con-
versely, inoculating two different inbred
mouse strains with the same gut bac-
teria leads to differences in host gene
expression between the two mouse strains
(20). Clearly, there is a complex interplay
between the genetics of the microbiota and
that of the host organism, which has only
recently begun to be appreciated.
GUT MICROBIOTA AS AN
EXPERIMENTAL PARAMETER
Examples in the literature have highlighted
the important and unexpected ways in
which gut microbiota can affect a variety
of experimental parameters. In a series of
studies,Vijay-Kumar et al. (13,21) reported
that although TLR5 null animals initially
had a colitis phenotype, when these mice
were “rederived” and their gut microbiota
altered, the colitis phenotype was greatly
attenuated, and instead the null animals
exhibited metabolic syndrome. In addition,
Lathrop et al. put forward a model by which
T-cells are educated not only by self/non-
self mechanisms, but also by microbiota-
derived “non-self” antigens (22). Accord-
ingly, they found that the presence or
absence of microbiota determined whether
T cells would induce colitis in mice. Finally,
Yang et al. reported that when the same
knockout mice were housed at two differ-
ent institutions, they had markedly differ-
ent microbiota profiles – and the mice at
one institution (MIT) were quite suscep-
tible to colitis, whereas mice at the other
institution (MHH) failed to develop any
significant pathology under the same con-
ditions (19). Unequivocally, altering gut
microbiota – even by housing animals at
different institutions – can have dramatic
effects on the phenotype observed.
GUT MICROBIOTA AND OBESITY AND
DIABETES
It is important to note that not only can
microbiota affect host physiology, but the
gut microbiota are not necessarily stable
over time. Rather, gut microbiota can
change or shift as a result of experimental
manipulation (in animals) or changes in
lifestyle or nutrition (in humans). It is now
appreciated that there are “shifts” in micro-
biota that occur in obesity in mice, rats,
and humans (23–26). In one study, Turn-
baugh et al. (25) examined human female
twin pairs concordant for leanness or obe-
sity, and found that obesity was associated
with phylum-level changes in microbiota.
In this study, both monozygotic and dizy-
gotic female twin pairs (and their mothers,
where available) were analyzed. Analysis of
fecal samples revealed that obese individ-
uals have reduced gut microbiota diver-
sity, and tended to have less Bacteroidetes
and more Actinobacteria. The authors sug-
gest that conditions of “abnormal energy
input” (i.e., obesity) may favor the growth
of a reduced diversity community. In sup-
port of these findings, a separate study
reported that ob/ob mice had a reduc-
tion in Bacteroidetes (27) as compared to
ob/+ or wild-type siblings. Furthermore,
in 12 obese humans who lost weight over
1 year by consuming either a fat restricted
or caloric restricted diet, there was a relative
increase in the abundance of Bacteroidetes
over time (28). Impressively, the increase
in Bacteroidetes in these individuals cor-
related with weight loss. Indeed, there is
an increasingly convincing link between
gut microbiota and obesity. These findings
highlight the importance of considering
and documenting gut microbiota compo-
sition in studies of obesity, as a change in
gut microbiota structure has a clear tie to
host pathology.
In addition, it has also been demon-
strated that type 2 diabetes in humans
is associated with changes in the gut
microbiota (not surprising, given the
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correlation between obesity and type 2
diabetes) (29–33). Specifically, it has been
reported that butyrate-producing bacteria
are reduced in type 2 diabetes (32), that
Bifidobacterium is lowered (33), and that
Firmicutes is decreased (30). Intriguingly,
it was also reported that the ratio of Bac-
teroidetes to Firmicutes (as well as the ratio
of Bacteroides–Prevotella to C. Coccoides–
E. rectale) correlated with plasma glucose
levels. Subsequently, it has been suggested
that manipulating gut microbiota may be
a therapeutic opinion for obesity and/or
type 2 diabetes (34). As reviewed in depth
by Kootte et al. (34), in addition to explor-
ing possible roles for prebiotics, probiotics,
and antibiotics as potential therapies, we
must also better understand the changes
in microbiota which appear to accompany
known treatments for obesity (i.e.,bariatric
surgery). In addition, we must continue
to explore a potential role for a variety
of microbiota metabolites in order to bet-
ter understand how and why changes in
microbiota affect the physiology of the
host.
WHAT’S A SCIENTIST TO DO?
Knowing that gut microbiota play such
an important and dynamic role in host
physiology, going forward we should take
into account (or at least, document) the
gut microbiota present in whole-animal
physiology experiments. This is especially
important in research focused on obesity
and diabetes, as these are areas in which gut
microbiota changes have been associated
with host pathology. As the study of the
gut microbiota requires a specialized and
complex set of knowledge, it may be pru-
dent for Universities, Companies, or other
Research Entities to establish core facili-
ties and/or collaborations to help facili-
tate such measurements. In addition, when
differences are found in measured phys-
iological parameters between researchers
at different institutions, gut microbiota
should be considered as one potential
explanation. Finally, as different strains of
microbiota produce different metabolites,
metabolomics may also be a useful tool
to help us understand the “end effect” of
microbiota on host function.
CONCLUSION
The gut microbiota is a complex tangle
of organisms, which easily outnumber the
number of cells in the host. When consid-
ering processes in the context of whole-
animal physiology, we must also consider
the contribution of these microorganisms
and their metabolites. The literature is rife
with examples of phenotypes which were
not easily replicated by other groups –
even when using the “same mice” – and
we should consider whether some of these
examples may be, in fact, due to the influ-
ence of gut microbiota. In the future, it
would be ideal for researchers to report
at least a basic characterization of gut
microbiota in research animals so that
any “institution-specific” effects can later
be examined. Understanding not only the
host and the microbiota, but the host–
microbiota interactions, will ultimately
give us a richer and fuller understanding
of host physiology.
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